ENTX

ENTERA BIO LTD

ENTX·M40527109·US·Common Stock·Healthcare - Biotechnology-13D/G

ENTX (ENTERA BIO LTD) is held by 17 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($525,521), CITADEL ADVISORS LLC ($272,590), MARSHALL WACE, LLP ($217,316). Net institutional sentiment: Mixed.

17
Holders
Avg rating(3 Elite)
$1.5M
Total Value
44% (19)
Fund Consensus
7 buying - 9 selling
ENTXSmart Money Verdict
View all
Held by 17 funds
3 elite
Who's Trading
InsiderBGBurshtein GregoryVest 88K shMay 7, 2026
InsiderYDYaacov-Garbeli DanaVest 58K shMay 7, 2026
InsiderGHGalitzer HillelVest 73K shMay 7, 2026
InsiderGJGermano Geno JBuy $26KMar 9, 2026
InsiderESEllis SeanBuy $12KMar 5, 2026
InsiderTJToledano Miranda JayneBuy $20KDec 29, 2025
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.2.6%Nov 14, 2025
ActivistOHOPKO HEALTH, INC.8.1%Apr 2, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
473,442(+338.4%)$525,5210.0%+21.84%
39
Increased
245,577(+510.4%)$272,5900.0%+14.47%
26
Decreased
195,780(-68.8%)$217,3160.0%-15.38%
0
Decreased
146,854(-1.2%)$163,0080.0%-24.25%
0
New
131,622$146,1000.0%+23.13%
31
Decreased
55,223(-90.7%)$61,2960.0%-10.77%
0
Decreased
36,830(-14.6%)$40,8810.0%-13.03%
0
Decreased
32,915(-55.6%)$36,5360.0%-16.81%
0
Unchanged
21,136$23,4600.0%-68.13%
0
Decreased
12,382(-99.0%)$13,7440.0%-5.89%
0
Decreased
12,000(-20.0%)$13,3200.0%-11.62%
0
Unchanged
10,000$11,1000.0%-28.71%
0
New
7,150$7,1500.0%+23.13%
25
Increased
3,212(+188x)$3,5650.0%+22.82%
15
New
400$4440.0%+23.13%
17
Unchanged
51$570.0%+126.03%
0
New
15,492$170.0%+23.13%
17
Exited
0(-100.0%)$23,9140.0%-33.00%
0
Exited
0(-100.0%)$125,9250.0%-30.69%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used